2015
Stevenson, Glenn W, et al. “The Mixed-Action Delta Mu Opioid Agonist MMP-2200 Does Not Produce Conditioned Place Preference But Does Maintain Drug Self-Administration in Rats, and Induces in Vitro Markers of Tolerance and Dependence.”. Pharmacol Biochem Behav, vol. 132, Jan. 2015, pp. 49-55, https://doi.org/10.1016/j.pbb.2015.02.022.
Slosky, Lauren M, and Vanderah, Todd W. “Therapeutic Potential of Peroxynitrite Decomposition Catalysts: A Patent Review.”. Expert Opin Ther Pat, Jan. 2015, pp. 1-24, https://doi.org/10.1517/13543776.2014.1000862.
Slosky, Lauren M, et al. “Use of Animal Models in Understanding Cancer-Induced Bone Pain.”. Cancer Growth Metastasis, vol. 8, no. Suppl 1, Jan. 2015, pp. 47-62, https://doi.org/10.4137/CGM.S21215.
2014
Grenald, Shaness A, et al. “Animal Models for Opioid Addiction Drug Discovery.”. Expert Opin Drug Discov, vol. 9, no. 11, Nov. 2014, pp. 1345-54, https://doi.org/10.1517/17460441.2014.966076.
Hegarty, Deborah M, et al. “Capsaicin-Responsive Corneal Afferents Do Not Contain TRPV1 at Their Central Terminals in Trigeminal Nucleus Caudalis in Rats.”. J Chem Neuroanat, vol. 61-62, Nov. 2014, pp. 1-12, https://doi.org/10.1016/j.jchemneu.2014.06.006.
Sancheti, Harsh, et al. “Hypermetabolic State in the 7-Month-Old Triple Transgenic Mouse Model of Alzheimer’s Disease and the Effect of Lipoic Acid: A 13C-NMR Study.”. J Cereb Blood Flow Metab, vol. 34, no. 11, Nov. 2014, pp. 1749-60, https://doi.org/10.1038/jcbfm.2014.137.
Bannister, Kirsty, et al. “Neuropathic Plasticity in the Opioid and Non-Opioid Actions of Dynorphin A Fragments and Their Interactions With Bradykinin B2 Receptors on Neuronal Activity in the Rat Spinal Cord.”. Neuropharmacology, vol. 85, Oct. 2014, pp. 375-83, https://doi.org/10.1016/j.neuropharm.2014.06.005.
Thompson, Brandon J, et al. “Hypoxia/Reoxygenation/Stress/Signals/an/Increase/in/Organic/Anion/Transporting/Polypeptide/1a4/(Oatp1a4)/at/the/Blood-Brain/Barrier:/Relevance/to/CNS/Drug/Delivery.”. J Cereb Blood Flow Metab, vol. 34, no. 4, Apr. 2014, pp. 699-07, https://doi.org/10.1038/jcbfm.2014.4.
Sancheti, Harsh, et al. “Reversal of Metabolic Deficits by Lipoic Acid in a Triple Transgenic Mouse Model of Alzheimer’s Disease: A 13C NMR Study.”. J Cereb Blood Flow Metab, vol. 34, no. 2, Feb. 2014, pp. 288-96, https://doi.org/10.1038/jcbfm.2013.196.
Kumar, S, et al. “Antibody-Directed Coupling of Endoglin and MMP-14 Is a Key Mechanism for Endoglin Shedding and Deregulation of TGF-β Signaling.”. Oncogene, vol. 33, no. 30, Jan. 2014, pp. 3970-9, https://doi.org/10.1038/onc.2013.386.
Zhang, Yan, et al. “Behavioral and Cellular Pharmacology Characterization of 17-Cyclopropylmethyl-3,14β-Dihydroxy-4,5α-Epoxy-6α-(isoquinoline-3’-Carboxamido)morphinan (NAQ) As a Mu Opioid Receptor Selective Ligand.”. Eur J Pharmacol, vol. 736, Jan. 2014, pp. 124-30, https://doi.org/10.1016/j.ejphar.2014.04.041.
Moutal, Aubin, et al. “Differential Neuroprotective Potential of CRMP2 Peptide Aptamers Conjugated to Cationic, Hydrophobic, and Amphipathic Cell Penetrating Peptides.”. Front Cell Neurosci, vol. 8, Jan. 2014, p. 471, https://doi.org/10.3389/fncel.2014.00471.
Wilson, Sarah M, et al. “Differential Regulation of Collapsin Response Mediator Protein 2 (CRMP2) Phosphorylation by GSK3ß and CDK5 Following Traumatic Brain Injury.”. Front Cell Neurosci, vol. 8, Jan. 2014, p. 135, https://doi.org/10.3389/fncel.2014.00135.
Lee, Yeon Sun, et al. “Discovery of Amphipathic Dynorphin A Analogues to Inhibit the Neuroexcitatory Effects of Dynorphin A through Bradykinin Receptors in the Spinal Cord.”. J Am Chem Soc, vol. 136, no. 18, Jan. 2014, pp. 6608-16, https://doi.org/10.1021/ja501677q.
Thompson, Brandon J, and Ronaldson, Patrick T. “Drug Delivery to the Ischemic Brain.”. Adv Pharmacol, vol. 71, Jan. 2014, pp. 165-02, https://doi.org/10.1016/bs.apha.2014.06.013.
White, Allison G, et al. “Environmental Arsenic Exposure and Microbiota in Induced Sputum.”. Int J Environ Res Public Health, vol. 11, no. 2, Jan. 2014, pp. 2299-313, https://doi.org/10.3390/ijerph110202299.
Rettberg, Jamaica R, et al. “Estrogen: A Master Regulator of Bioenergetic Systems in the Brain and Body.”. Front Neuroendocrinol, vol. 35, no. 1, Jan. 2014, pp. 8-30, https://doi.org/10.1016/j.yfrne.2013.08.001.
Hofmann, Mackenzie E, et al. “External QX-314 Inhibits Evoked Cranial Primary Afferent Synaptic Transmission Independent of TRPV1.”. J Neurophysiol, vol. 112, no. 11, Jan. 2014, pp. 2697-706, https://doi.org/10.1152/jn.00316.2014.
Irwin, Ronald W, et al. “Frontiers in Therapeutic Development of Allopregnanolone for Alzheimer’s Disease and Other Neurological Disorders.”. Front Cell Neurosci, vol. 8, Jan. 2014, p. 203, https://doi.org/10.3389/fncel.2014.00203.
Garbe, James C, et al. “Immortalization of Normal Human Mammary Epithelial Cells in Two Steps by Direct Targeting of Senescence Barriers Does Not Require Gross Genomic Alterations.”. Cell Cycle, vol. 13, no. 21, Jan. 2014, pp. 3423-35, https://doi.org/10.4161/15384101.2014.954456.
Lochhead, JJ, and Thorne, R.G. “Intranasal Drug Delivery to the Brain ”. Drug Delivery to the Brain, Springer, 2014, pp. 401-3.
Largent-Milnes, Tally M, et al. “Physiological Temperatures Drive Glutamate Release onto Trigeminal Superficial Dorsal Horn Neurons.”. J Neurophysiol, vol. 111, no. 11, Jan. 2014, pp. 2222-31, https://doi.org/10.1152/jn.00912.2013.
Pan, Christopher C, et al. “Src-Mediated Post-Translational Regulation of Endoglin Stability and Function Is Critical for Angiogenesis.”. J Biol Chem, vol. 289, no. 37, Jan. 2014, pp. 25486-96, https://doi.org/10.1074/jbc.M114.578609.
Lee, Yeon Sun, et al. “Structure-Activity Relationships of Non-Opioid [des-Arg(7)]-Dynorphin A Analogues for Bradykinin Receptors.”. Bioorg Med Chem Lett, vol. 24, no. 21, Jan. 2014, pp. 4976-9, https://doi.org/10.1016/j.bmcl.2014.09.033.
Fernandes, Steve M, et al. “Synthesis and Evaluation of Bivalent Ligands for Binding to the Human Melanocortin-4 Receptor.”. Bioorg Med Chem, vol. 22, no. 22, Jan. 2014, pp. 6360-5, https://doi.org/10.1016/j.bmc.2014.09.055.